J. Mark Farrar is a partner and the global practice leader of the Life Sciences Governance, Risk Management and Compliance practice. He advises clients in the U.S., Europe, South America, Africa and Asia on complex issues such as SEC financial accounting investigations, white collar crime, off-label allegations, Foreign Corrupt Practices Act matters, False Claims Act damages, violations of the Anti-Kickback Statute, pharmaceutical sales and marketing compliance, economic damages, global transparency, privacy and GDPR issues, risk assessments, patient support programs and various auditing and monitoring assessments.

Mark served for over a year as the interim global Chief Compliance Officer for a $4B medical device company with over 50 world-wide locations. He built the compliance program and established a global team, as well as implemented a comprehensive third party due diligence system to manage the anti-bribery / anti-corruption risk of its distributors.

Mark also serves as an Independent Review Organization expert and as an advisor on state and federal healthcare compliance issues. He also has assisted in the development of alternative methodologies to help refute multi-billion dollar claims brought forth by government agencies.